Endothelial TKK1 deficiency reduces eNOS MRNA levels, promoting endothelial dysfunction and atherogenesis
Estimating the magnitude of LDL-C reduction needed to overcome the increased risk of atherosclerotic cardiovascular events caused by LP(A) to guide clinical management
Endothelial cannabinoid receptor CB1 deficiency decreases OxLDL uptake and attenuates vascular inflammation in atherosclerosis